Characterization and optimization of in vitro assay conditions for (1,3)β-Glucan synthase activity from Aspergillus fumigatus and Candida albicans for enzyme inhibition screening

Journal of Antibiotics

Volumn 51, Issue 7, 1998, Pages 665-675

  Wood, Rebecca L ^a   Miller, Tamara K ^a   Wright, Amy ^b   McCarthy, Peter ^b   Taft, Cathy S ^a   Pomponi, Shirley ^b   Selitrennikoff, Claude P ^a  

^a Box B 111   (United States)

^b FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID; ACULEACIN A; BUFFER; CASPOFUNGIN; CELLOBIOSE; CILOFUNGIN; ECHINOCANDIN B; EDETIC ACID; ENZYME INHIBITOR; FLUORIDE SODIUM; GLUCAN SYNTHASE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); PAPULACANDIN B; SODIUM DIHYDROGEN PHOSPHATE; SUCROSE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; BIOASSAY; CANDIDA ALBICANS; CONTROLLED STUDY; CYTOLYSIS; DRUG PURIFICATION; DRUG SCREENING; ENZYME ACTIVITY; ENZYME INHIBITION; NONHUMAN; PH; PRIORITY JOURNAL; REPRODUCIBILITY;

ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS;

EID: 0031679779     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.51.665     Document Type: Article

References (31)

1. HOEPRICH, P.: Antifungal chemotherapy. Prog. Drug Res. 44: 87-127, 1995
2. SAMONIS, G. & D. BAFALOUKOS: Fungal infections in cancer patients: an escalating problem. In Vivo 6: 183-194, 1992
3. RHODES, J.; H. JENSEN, A. NILIUS, C. R. CHITAMBAR, S. G. FARMER, R. G. WASHBURN, P. E. STEELE & T. W. AMLUNG: Aspergillus and aspergillosis. J. Med. Vet. Myc. 30: 51-57, 1992
4. SARAL, R.: Candida and aspergillus infections in immunocompromised patients: an overview. Rev. Infect. Dis. 13: 487-492, 1991
5. LORTHOLARY, O. & B. DUPONT: Antifungal prophylaxis during neutropenia and immunodeficiency. Clinical Microbiol. Reviews 10: 477-504, 1997
6. ODDS, F.: Resistance of clinically important yeasts to antifungal agents. Internat. J. Antimicrob. Agents 6: 145-147, 1996
7. KURTZ, M.: New antifungal drug targets: A vision for the future. ASM News 64: 31-39, 1988
8. ORLEAN, P. A. B.: (1,3)-β-D-Glucan synthase from budding and filamentous cultures of the dimorphic fungus Candida albicans. Eur. J. Biochem. 127: 397-403, 1982
9. RUIZ-HERRERA, J.: Biosynthesis of β-glucans in fungi. Antonie van Leeuwenhoek. 60: 73-81, 1991
10. FROST, D. J.; K. BRANDT, J. CAPOBIANCO & R. GOLDMAN: Characterization of (1,3)-β-glucan synthase in Candida albicans: microsomal assay from the yeast or mycelial morphological forms and a permeabilized whole-cell assay. Microbiol. 140: 2239-2246, 1994
11. HRMOVA, M.; C. S. TAFT & C. P. SELITRENNIKOFF: 1,3-β-Glucan synthase of Neurospora crassa: partial purification and characterization of solubilized enzyme activity. Exp. Mycol. 19: 153-161, 1989
12. TAFT, C. S.; C. S. ENDERLIN & C. P. SELITRENNIKOFF: A high throughput in vitro assay for fungal (1,3)β-glucan synthase inhibitors. J. Antibiotics 47: 1001-1009, 1994
13. ORLEAN, P. A. B. & S. M WARD: Sodium fluoride stimulates (1,3)-β-D-glucan synthase from Candida albicans. FEMS Microbiol. Lett. 18: 31-35, 1983
14. TANG, J. & T. R. PARR, Jr.: W-1 solubilization and kinetics of inhibition by cilofungin of Candida albicans (1,3)-β-glucan synthase. Antimicrob. Agents Chemother. 35: 99-103, 1991
15. BARTNIKI-GARCIA, S.: Cell wall chemistry, morphogenesis, and taxonomy of fungi. Annu. Rev. Microbiol. 22: 87, 1968
16. BEAVAIS, A.; R. DRAKE, K. NG, M. DIAQUIN & J. LATGE: Characterization of the 1,3β-glucan synthase of Aspergillus fumigatus. J. Gen. Microbiol. 139: 3071-3078, 1993
17. BEAULIEU, D.; J. TANG, D. ZECKNER & T. PARR: Correlation of cilofungin efficacy with its activity against Aspergillus fumigatus (1,3,)-β-D-glucan synthase, FEMS Microbiol. Letters. 108: 133-138, 1993
18. BEAULIEU, D.; J. TANG, S. B. YAN, J. M. VESSELS, J. A. RADDING & T. R. PARR: Characterization and cilofungin inhibition of solubilized Aspergillus fumigatus (1,3)-β-D-glucan synthase. Antimicrob. Agents Chemother 38: 937-944, 1994
19. KURTZ, M. B.; I. B. HEATH, J. MARRINAN, S. DREIKORN, J. ONISHI & C. DOUGLAS: Morphological effects of lipopeptides against Aspergillus fumigatus correlate with activities against (1,3)-β-D-glucan synthase. Antimicrob. Agents Chemother 38: 1480-1489, 1994
20. MANNING, M. & T. G. MITCHELL: Strain variation and morphogenesis of yeast- and mycelial-phase Candida albicam in low-sulfate, synthetic medium. J, Bacteriology 142: 714-719, 1980
21. TAFT, C. S.; T. STARK & C. P. SELITRENNIKOFF: Cilofungin (LY121019) inhibits Candida albicans (1-3)-β-D-glucan synthase activity. Antimicrob. Agents Chemother 32: 1901-1903, 1988
22. PERRELLA, F. EZ-FIT: A practical curve-fitting microcomputer program for the analysis of enzyme kinetic data on IBM-PC compatible computers. Anal. Biochem. 174: 437-447, 1988
23. GOODAY, G. W. & A. DE ROUSSETT-HALL: Properties of chitin synthetase from Coprinus cinereus. J. Gen. Microbiol. 89: 137-145, 1975
24. BRADFORD, M. M.: A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-2541, 1976
25. TKACZ, J.: Glucan biosynthesis in fungi and its inhibition, In Emerging targets in antibacterial and antifungal chemotherapy, Ed., J. SUTCLIFFE and N. H. GEORGOPAPADAKOU, pp. 495-523. Chapman and Hall. New York, 1992
26. DRGONOVA, J.; T. DRGON, K. TANAKA, R. KOLLAR, G. C. CHEN, R. A. FORD, C. S. CHAN, Y. TAKAI & E. CABIB: Rholp, a yeast protein at the interface between cell polarization and morphogenesis. Science 272: 277-279, 1996
27. MAZUR, P. & W. BAGINSKY: In vitro activity of 1,3-β-D-glucan synthase requires the GTP-binding protein Rhol. J. Biol. Chem. 271: 14604-14609, 1996
28. QUIGLEY, D. R. & C. P. SELITRENNIKOFF: β-Linked disaccharides stimulate, but do not act as a primer for (1,3)-glucan synthase of Neurospora crassa. Current Microbiol. 15: 181-184, 1987
29. CLELAND, W. W.: The kinetics of enzyme catalyzed reactions with two or more substrates or products. Rate equations and I Nomenclature. Biolic. Biophys. Acta. 67: 104-137, 1963
30. TAFT, C. S.; M. ZUGEL & C. P. SELITRENNIKOFF: In vitro inhibition of stable 1,3-β-D-glucan synthase activity from Neurospora crassa. J. Enzyme Inhibition 5: 41-49, 1991
31. CORMICAN, M. & M. PFALLER: Standardization of antifungal susceptibility testing. J. Antimicrob. Chemother. 38: 561-578, 1996